Chinese medicine preparation for treating cardiovascular and cerebrovascular and preparing method

A technology of cardiovascular and cerebrovascular diseases and traditional Chinese medicine preparations, which is applied in the field of traditional Chinese medicine preparations and preparations for the treatment of cardiovascular and cerebrovascular diseases, and can solve problems such as side effects

Inactive Publication Date: 2006-03-08
FUKANGREN BIO PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Commonly used anti-myocardial ischemic drugs include: nitrates, β-receptor blockers, Ca2+ channel blockers, A...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0119] It is characterized in that it contains three kinds of natural medicinal materials, ginseng, salvia miltiorrhiza and radices japonicus.

[0120] The preparation method of the injection is as follows:

[0121] Extract ginsenosides from ginseng: Weigh 2000g of ginseng medicinal materials, add 65-75% ethanol to extract twice, after recovering the ethanol from the extract, let it stand and centrifuge, pass the centrifugate through macroporous resin, elute, analyze, and dry the solution after concentration. The ointment was extracted with ethanol, and the extract was concentrated and dried to obtain 42 g of ginsenosides.

[0122] Salvia miltiorrhiza extracts salvianolic acid: Weigh 4000g of salvia miltiorrhiza, warm soak in water, centrifuge the warm soak solution, add acid to the centrifuge to adjust the pH to 2-3, let it stand for layers, remove the slag of the lower layer, wash the slag of the lower layer until neutral, and obtain salvianol Acid component 73g.

[0123] ...

Embodiment 2

[0131] It is characterized in that it contains four natural medicinal materials, ginseng, salvia miltiorrhiza, Ophiopogon japonicus and calamus calamus.

[0132] The preparation method of the injection is as follows:

[0133] Extract ginsenosides from ginseng: Weigh 2000g of ginseng medicinal materials, add 65-75% ethanol to extract twice, after recovering the ethanol from the extract, let it stand and centrifuge, pass the centrifugate through macroporous resin, elute, analyze, and dry the solution after concentration. The ointment was extracted with ethanol, and the extract was concentrated and dried to obtain 51 g of ginsenosides.

[0134] Salvia miltiorrhiza extracts salvianolic acid: Weigh 4000g of salvia miltiorrhiza, warm soak in water, centrifuge the warm soak solution, add acid to the centrifuge to adjust the pH to 2-3, let it stand for layers, remove the slag of the lower layer, wash the slag of the lower layer until neutral, and obtain salvianol Acid component 64g. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a Chinese medicine preparation for curing angiocardiopathy and cerebrovascular disease and its preparation method. Said preparation is made up by using Chinese medicinal materials of ginseng, salvia root, ophiopogon tuber and acorus root through a certain preparation process.

Description

Technical field: [0001] The invention relates to a traditional Chinese medicine composition and preparation method for treating cardiovascular and cerebrovascular diseases. On the basis of adding Shichangpu to form a prescription for treating cardiovascular and cerebrovascular diseases. Background technique: [0002] Cardiovascular disease is the main cause of human morbidity and death, accounting for one-third of the total mortality. In China, about 2.4 million patients die of cardiovascular disease every year, accounting for 34% of the total mortality rate, exceeding the mortality rate caused by cancer. Survivors are sick and disabled, which poses a huge threat to the life of the patient, and at the same time, the quality of life is seriously affected, and it also imposes a heavy burden on the patient's family and the entire society. [0003] With the improvement of people's living standards in China, the number of people suffering from cardiovascular disease is increasi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8965A61K36/882A61K36/258A61K36/53A61K9/20A61K9/48A61K9/08A61P9/00
Inventor 刘智谋刘洪林
Owner FUKANGREN BIO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products